Neko Health develops scanning technology for preventive healthcare and early detection.
Neko Health has raised $260.0M in total funding. The most recent round was Series B. The last funding was announced in January 2025.
Neko Health's investors include General Catalyst, Lightspeed Venture Partners, Lakestar, Atomico, O.G. Venture Partners.
Neko Health is headquartered in Stockholm, Sweden.
Neko Health develops scanning technology for preventive healthcare and early detection.
Neko Health is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neko Health — Funding & Investors." VCBacked, January 22, 2025, https://www.vcbacked.co/company/neko-health. Accessed July 19, 2026.
VCBacked. (2025). Neko Health — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/neko-health
{{cite web |title=Neko Health — Funding & Investors |url=https://www.vcbacked.co/company/neko-health |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated